A 24-Week Open-Label Study Evaluating the Efficacy and Safety of OPN-375 186 μg Twice a Day (BID) in Adults With Bilateral Nasal Polyps Using Nasoendoscopic Video
Phase of Trial: Phase III
Latest Information Update: 08 Jul 2019
Price : $35 *
At a glance
- Drugs Fluticasone propionate (Primary)
- Indications Nasal polyps
- Focus Therapeutic Use
- Sponsors OptiNose
- 03 Jul 2019 Status changed from active, no longer recruiting to completed.
- 26 Apr 2019 Planned End Date changed from 30 Apr 2019 to 30 May 2019.
- 26 Apr 2019 Planned primary completion date changed from 30 Mar 2019 to 30 Apr 2019.